Buying a pharmacy goes well beyond price negotiations. NHS contracts, compliance obligations, staffing costs, and the financial condition of the business all require proper scrutiny before you reach the point of signing.
Many buyers move through this stage too quickly and only realise what was missed once the purchase is complete. Here are the financial mistakes that come up most often and how to deal with them before they become a problem.
1. Skipping thorough financial due diligence
A pharmacy can look profitable on paper, but the figures presented during a sale do not always reflect the full financial position. Many buyers accept what is in front of them without examining what sits behind the numbers.
What to examine during due diligence
- At least three years of annual accounts
- Monthly management accounts to understand income trends
- Dispensing volumes and NHS income over time
- Private sales, services, and any other revenue streams
- Outstanding debts and any existing HMRC obligations
- Whether recent profits have been driven by factors that will not continue after the sale
A proper due diligence review looks at how sustainable the earnings actually are, not just what has been reported. An accountant with pharmacy experience knows what to look for and where the risks tend to sit. A generalist will not, and that gap in knowledge can cost you significantly after completion.
2. Misunderstanding the purchase structure
There are two main ways to buy a pharmacy, and many buyers select one without fully understanding what they are taking on financially.
Asset purchase vs share purchase
- Asset purchase — you buy the business assets only, and most historic liabilities remain with the seller
- Share purchase — you buy the company shares and take on everything that comes with them, including any undisclosed tax liabilities, HMRC debts, or historic NHS clawback issues
The tax treatment and liability exposure are very different between the two. Choosing the wrong structure can leave you with costs you were not expecting. This decision should be made at the very beginning of the process, ideally before any heads of terms are signed.
3. Overlooking working capital requirements
The purchase price gets most of the attention, but many buyers give very little thought to the cash needed to actually run the business once they take over. This is a frequent reason why new pharmacy owners find themselves short of funds within the first few weeks.
Costs that buyers frequently underestimate
- Initial stock and medication inventory
- Staff wages during the handover period
- Rent, business rates, and utility bills
- Legal and professional fees
- Cash flow gaps caused by the delay in receiving NHS payments
Before committing to a purchase price, you should have a clear cash flow forecast that accounts for what you will need to spend in the first few months, including the wait between taking ownership and receiving your first NHS reimbursements.
4. Not accounting for Category M clawback
This is one of the most pharmacy-specific financial risks in any acquisition and one that buyers without sector knowledge regularly miss.
What it is and why it matters
NHSE reimburses pharmacies for medicine costs based on Drug Tariff prices. Where the actual cost of medicines is lower than the reimbursement paid, a clawback is applied retrospectively. If the seller has been receiving higher reimbursements than the actual costs incurred, you as the buyer may inherit that liability without knowing it.
How to protect yourself
- Ask for a full review of the pharmacy’s Category M position as part of due diligence
- Make sure any identified exposure is resolved before completion or factored into the purchase price
- Work with an accountant who has a working knowledge of NHS reimbursement
5. Ignoring VAT implications
VAT is an area where buyers frequently make costly assumptions. Errors here can result in VAT being charged where it should not be, or in post-purchase filing mistakes that attract HMRC penalties.
Key VAT considerations
- Transfer of a going concern — if the transaction qualifies under this classification, it may be VAT-exempt, which can reduce the overall cost of the purchase and help post-acquisition cash flow
- Partial VAT exemption — most pharmacies sit in a partially exempt VAT position because prescription dispensing is VAT-exempt while over-the-counter sales are taxable
- Misunderstanding the pharmacy’s VAT position before purchase can lead to significant errors in the transaction itself and in your ongoing VAT returns
VAT advice relevant to pharmacy acquisitions should be taken before contracts are exchanged.
6. Underestimating staff and TUPE Obligations
Staffing is a significant cost in any pharmacy, and overlooking employment contracts during the acquisition process can lead to financial surprises after completion.
What TUPE means for buyers
Under the Transfer of Undertakings Protection of Employment regulations, all existing employees transfer to the new owner automatically at the point of sale in an asset purchase. In practical terms, this means:
- You take on all existing employment contracts and their terms
- Dismissing staff because of the ownership change can result in unfair dismissal claims
- Redundancy costs need to be included in your overall acquisition budget
- Contractual benefits such as enhanced sick pay or pension arrangements carry across to you
All employee contracts, salary levels, and any unresolved HR matters should be reviewed during due diligence, with any associated costs built into your financial planning.
7. Choosing the wrong professional advisers
Pharmacy transactions have specific financial, regulatory, and contractual complexities that advisers without sector experience are not well-placed to handle. Using a general accountant or solicitor who has never worked on a pharmacy acquisition can mean that risks go unnoticed, valuations are off, and tax planning opportunities are missed.
What specialist advisers bring to the process
- A working understanding of NHS contract structures and income analysis
- Experience identifying Category M clawback exposure
- Knowledge of pharmacy VAT rules and partial exemption
- Business valuations based on sector-specific benchmarks
- Tax planning structured around pharmacy ownership
The fees you pay for the right advisers will be far less than the cost of sorting out problems that arise from using the wrong ones.
How 3E'S accountants can help
Purchasing a pharmacy involves far more than agreeing a price and signing contracts. At 3E’S Accountants, we have worked with pharmacy buyers across the UK for over 15 years. From financial due diligence and purchase structuring to tax planning, cash flow forecasting, and TUPE assessments, we make sure you have a complete financial picture before you sign anything. Get in touch with us to arrange a consultation.
